- 3.0Impact Factor
- 3.7CiteScore
- 23 daysTime to First Decision
Cardiovascular Risk Stratification in Hypertension
This special issue belongs to the section “Cardiology“.
Special Issue Information
Dear colleagues,
Hypertension is the leading modifiable factor associated with stroke, coronary events, and cardiovascular (CV) death. However, hypertensive patients represent a heterogeneous group with different CV risks due to different organ damage and comorbidities, and both therapeutic options as well as targets change depending on a patient's global CV risk. Therefore, stratifying CV risk as best as possible is essential for predicting prognoses and to personalize target therapies.
We are pleased to invite you to submit an article for this Special Issue, titled “Cardiovascular Risk Stratification in Hypertension”, which will be published in Diseases (IF: 2.9). The main purpose of this Special Issue is to collect the most recent clinical and experimental evidence about new and traditional indices associated with CV risk in hypertensive patients, as well as about the scores used to estimate CV risk. In particular, considerable relevance will be given to the new genetic, molecular, clinical, and instrumental indices or markers that could improve the stratification of cardiovascular risk in hypertensive individuals.
In this Special Issue, original research articles and reviews are welcome.
I look forward to receiving your contributions.
Dr. Giulio Geraci
Dr. Giuseppe Mulè
Dr. Giacomo Pucci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hypertension
- cardiovascular risk
- cardiovascular death
- risk score
- organ damage
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

